General Nurse Practitioner News

NP

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Valgimigli M et al. – Tirofiban administration reduces mortality, the composite of death or MI and increases minor bleedings when compared with placebo. An early ischaemic hazard disfavouring tirofiban was noted when compared with abciximab in studies based on 10 but not 25 mug/kg tirofiban bolus regimen.

Related Articles

Effect of High Bolus Dose Tirofiban on the Inflammatory Response Following Percutaneous Coronary Intervention
Clinical Cardiology, 10/21/09    Relevance Score: 87%

Comparison of Bivalirudin Monotherapy Versus Unfractionated Heparin Plus Tirofiban in Patients With Diabetes Mellitus Undergoing Elective Percutaneous Coronary Intervention
The American Journal of Cardiology, 10/27/09    Relevance Score: 83%

Successful treatment of saphenous venous graft thrombus by tirofiban infusion
Heart & Lung; The Journal of Acute and Critical Care, 10/27/09    Relevance Score: 82%

Resolution of late sirolimus-eluting stent thrombosis after tirofiban treatment
Heart and Vessels, 10/07/09    Relevance Score: 82%

Today in General Medicine...keeping you current

The relationship between primary health care organization and quality of diabetes care
The European Journal of General Practice, 12/17/09

Nurses 'must' control of the nutritional needs of stroke patients
British Journal of Nursing, 12/17/09

Somatoform disorders with pain as the predominant symptom
Schmerz, 12/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address